“Prognostic Use Of Fasting Lipid Profile, Erythrocyte Sedimentation Rate And C - Reactive Protein In The Management Of Hypertensive Individuals With Chronic Kidney Disease”. 2022. Journal of Pharmaceutical Negative Results 13 (November): 1702-6. https://doi.org/10.47750/pnr.2022.13. S05.267.